Biosynthema Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Biosynthema General Information

Description

Provider of drug development and discovery services. The company develops and researches on radiopharmaceuticals for diagnostic and therapeutic applications.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 4041 Forest Park Avenue
  • Saint Louis, MO 63108
  • United States
+1 (314) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosynthema Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biosynthema‘s full profile, request access.

Request a free trial

Biosynthema Executive Team (1)

Name Title Board Seat Contact Info
Jack Erion Ph.D President and Chief Executive Officer
To view Biosynthema’s complete executive team members history, request access »